WordNet

(botany) a tiny outgrowth on the surface of a petal or leaf
a small nipple-shaped protuberance concerned with taste, touch, or smell; "the papillae of the tongue"
a small projection of tissue at the base of a hair or tooth or feather
of or relating to or resembling papilla (同)papillose

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 脳室上衣細胞腫 ependymoma
2. 脊髄腫瘍 spinal cord tumors
3. 神経膠腫の分類 classification of gliomas
4. 松果体部腫瘍 pineal gland masses
5. 多発神経根症：脊柱管狭窄症、感染症、癌、および炎症性神経根症候群 polyradiculopathy spinal stenosis infectious carcinomatous and inflammatory nerve root syndromes

Genomic characterization of ependymomas reveals 6q loss as the most common aberration.

Olsen TK1, Gorunova L1, Meling TR2, Micci F1, Scheie D3, Due-Tønnessen B2, Heim S1, Brandal P1.
Oncology reports.Oncol Rep.2014 Aug;32(2):483-90. doi: 10.3892/or.2014.3271. Epub 2014 Jun 16.
Ependymomas are rare tumors of the central nervous system (CNS). They are classified based on tumor histology and grade, but the prognostic value of the WHO grading system remains controversial. Treatment is mainly surgical and by radiation. An improved knowledge of ependymoma biology is important t
PMID 24939246

A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.

Fouladi M1, Perentesis JP, Phillips CL, Leary S, Reid JM, McGovern RM, Ingle AM, Ahern CH, Ames MM, Houghton P, Doyle LA, Weigel B, Blaney SM.
Pediatric blood & cancer.Pediatr Blood Cancer.2014 Jul;61(7):1246-51. doi: 10.1002/pbc.25023. Epub 2014 Mar 24.
BACKGROUND: We report results of a phase I trial designed to estimate the maximum tolerated dose (MTD), describe dose-limiting toxicities (DLT), and characterize the pharmacokinetic profile of MK-2206, an AKT inhibitor, in children with refractory or recurrent malignancies.PROCEDURE: MK-2206 was adm
PMID 24664955

Antony R1, Wong KE, Patel M, Olch AJ, McComb G, Krieger M, Gilles F, Sposto R, Erdreich-Epstein A, Dhall G, Gardner S, Finlay JL.
Pediatric blood & cancer.Pediatr Blood Cancer.2014 Jul;61(7):1195-201. doi: 10.1002/pbc.24996. Epub 2014 Feb 24.
BACKGROUND: Recurrence occurs in almost 50% of patients with intracranial ependymoma, and their outcome following recurrence is poor.METHODS: We retrospectively reviewed the medical records of 22 patients with intracranial ependymoma and subsequent relapse(s) (59 recurrences) treated at Children's H
PMID 24615997

金崎彰三,田北親寛,東努,吉岩豊三,津村弘
整形外科と災害外科 58(4), 688-692, 2009
… 指摘された．間欠性跛行を認めたが，下肢筋力，感覚及び深部腱反射は正常であり，膀胱直腸障害はなかった．MRIにてL4-S1にかけて硬膜内腫瘍を認めた．腫瘍摘出術を施行したところ，病理組織はmyxopapillary ependymoma（MPE）であった．MPEの治療は被膜ごとの全摘出が推奨されているが，腫瘍は一塊に摘出できなかったため，40Gyの放射線治療を追加した．術後9ケ月で経過観察中であるが再発は認めていない．MPEの再発は術 …
NAID 130004460900

KAWAHARA Ichiro,TOKUNAGA Yoshiharu,YAGI Nobuhiro,ISEKI Masachika,ABE Kuniko,HAYASHI Tomayoshi
Neurologia medico-chirurgica 47(12), 568-571, 2007-12-15
… A 48-year-old female presented with an extremely rare primary tumor of the pineal region with papillary features manifesting as morning headaches persisting for 1 month. … Histological examination found a distinctive papillary growth pattern in which the vessels were covered by multiple layers of tumor cells. …
NAID 110006532334